Tenaya Therapeutics Inc (NASDAQ: TNYA) Could Soar To Much Higher Prices In Coming Months

In the last trading session, 2.97 million Tenaya Therapeutics Inc (NASDAQ:TNYA) shares changed hands as the company’s beta touched 2.87. With the company’s per share price at $0.49 changed hands at $0.04 or 8.54% during last session, the market valuation stood at $79.39M. TNYA’s last price was a discount, traded about -853.06% off its 52-week high of $4.67. The share price had its 52-week low at $0.36, which suggests the last value was 26.53% up since then.

Analysts gave the Tenaya Therapeutics Inc (TNYA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TNYA as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.

Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information

Instantly TNYA was in green as seen at the end of in last trading. With action 18.71%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -65.87%, with the 5-day performance at 18.71% in the green. However, in the 30-day time frame, Tenaya Therapeutics Inc (NASDAQ:TNYA) is 8.44% up.

Tenaya Therapeutics Inc (TNYA) estimates and forecasts

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -15.48%. The 2025 estimates are for Tenaya Therapeutics Inc earnings to increase by 40.19%.

Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders

RA CAPITAL MANAGEMENT, L.P. holds the second largest percentage of outstanding shares, with 8.8935% or 7.62 million shares worth $23.63 million as of 2024-06-30.

Among Mutual Funds, the top two as of Dec 31, 2024 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 2.06 shares estimated at $1.01 million under it, the former controlled 1.27% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 0.90% of the shares, roughly 1.46 shares worth around $0.71 million.